UK markets closed

China Shineway Pharmaceutical Group Limited (2877.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
9.350+0.090 (+0.97%)
At close: 04:08PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
4,516,538
4,516,538
3,950,636
3,223,550
2,655,701
Cost of revenue
1,122,419
1,122,419
1,012,322
813,214
667,855
Gross profit
3,394,119
3,394,119
2,938,314
2,410,336
1,987,846
Operating expenses
Research development
110,462
110,462
117,454
112,711
99,705
Selling general and administrative
2,308,122
2,308,122
2,098,456
1,756,239
1,458,828
Total operating expenses
2,418,584
2,418,584
2,215,910
1,868,950
1,558,533
Operating income or loss
975,535
975,535
722,404
541,386
429,313
Interest expense
2,737
2,737
630
1,254
16,600
Income before tax
1,240,253
1,240,253
917,025
720,103
395,024
Income tax expense
270,743
270,743
194,252
163,429
99,991
Income from continuing operations
969,510
969,510
722,773
556,674
295,033
Net income
969,510
969,510
722,773
556,674
295,033
Net income available to common shareholders
969,510
969,510
722,773
556,674
295,033
Basic EPS
1.17
1.28
0.96
0.74
0.39
Diluted EPS
1.17
1.28
0.96
0.74
0.39
Basic average shares
755,400
755,400
755,400
755,141
756,495
Diluted average shares
755,400
755,400
755,400
755,141
756,747